Internet-based treatment for older adults with depression and co-morbid cardiovascular disease: protocol for a randomised, double-blind, placebo controlled trial

被引:28
|
作者
Cockayne, Nicole L. [1 ]
Glozier, Nick [1 ,2 ,5 ]
Naismith, Sharon L. [1 ]
Christensen, Helen [3 ]
Neal, Bruce [4 ]
Hickie, Ian B. [1 ]
机构
[1] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Sydney Med Sch, Discipline Psychiat, Sydney, NSW 2006, Australia
[3] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 0200, Australia
[4] George Inst Global Hlth, Sydney, NSW 2050, Australia
[5] Univ Sydney, Sydney Med Sch, Discipline Sleep Med, Sydney, NSW 2006, Australia
来源
BMC PSYCHIATRY | 2011年 / 11卷
关键词
CORONARY-HEART-DISEASE; COGNITIVE-BEHAVIORAL THERAPY; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; MEMORY DECLINE; MENTAL-HEALTH; RISK-FACTORS; INTERVENTIONS; IMPAIRMENT; VALIDITY;
D O I
10.1186/1471-244X-11-10
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Depression, cardiovascular disease (CVD) risk factors and cognitive impairment are important causes of disability and poor health outcomes. In combination they lead to an even worse prognosis. Internet or web-based interventions have been shown to deliver efficacious psychological intervention programs for depression on a large scale, yet no published studies have evaluated their impact among patients with co-existing physical conditions. The aims of this randomised controlled trial are to determine the effects of an evidence-based internet intervention program for depression on depressive mood symptoms, cognitive function and treatment adherence in patients at risk of CVD. Methods/Design: This study is an internet-based, double-blind, parallel group randomised controlled trial. The trial will compare the effectiveness of online cognitive behavioural therapy with an online attention control placebo. The trial will consist of a 12-week intervention phase with a 40-week follow-up. It will be conducted in urban and rural New South Wales, Australia and will recruit a community-based sample of adults aged 45 to 75 years. Recruitment, intervention, cognitive testing and follow-up data collection will all be internet-based and automated. The primary outcome is a change in severity of depressive symptoms from baseline to three-months. Secondary outcomes are changes in cognitive function and adherence to treatment for CVD from baseline to three, six and 12-months. Discussion: Prior studies of depression amongst patients with CVD have targeted those with previous vascular events and major depression. The potential for intervening earlier in these disease states appears to have significant potential and has yet to be tested. Scalable psychological programs using web-based interventions could deliver care to large numbers in a cost effective way if efficacy were proved. This study will determine the effects of a web-based intervention on depressive symptoms and adherence to treatment among patients at risk of CVD. In addition it will also precisely and reliably define the effects of the intervention upon aspects of cognitive function that are likely to be affected early in at risk individuals, using sensitive and responsive measures.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial
    Kobayashi, Y.
    Kuhara, T.
    Oki, M.
    Xiao, J-Z
    BENEFICIAL MICROBES, 2019, 10 (05) : 511 - 520
  • [22] Trajectories of change and long-term outcomes in a randomised controlled trial of internet-based insomnia treatment to prevent depression
    Batterham, Philip J.
    Christensen, Helen
    Mackinnon, Andrew J.
    Gosling, John A.
    Thorndike, Frances P.
    Ritterband, Lee M.
    Glozier, Nick
    Griffiths, Kathleen M.
    BJPSYCH OPEN, 2017, 3 (05): : 228 - 235
  • [23] Repetitive transcranial magnetic stimulation for depression after basal ganglia ischaemic stroke: protocol for a multicentre randomised double-blind placebo-controlled trial
    Tang, Ying
    Chen, Aimin
    Zhu, Shuzhen
    Yang, Li
    Zhou, Jiyuan
    Pan, Suyue
    Shao, Min
    Zhao, Lianxu
    BMJ OPEN, 2018, 8 (02):
  • [24] Internet-based treatment of major depression for patients on a waiting list for inpatient psychotherapy: protocol for a multi-centre randomised controlled trial
    Jo Annika Reins
    David Daniel Ebert
    Dirk Lehr
    Heleen Riper
    Pim Cuijpers
    Matthias Berking
    BMC Psychiatry, 13
  • [25] Silymarin (Milk Thistle) Treatment of Adults With Gambling Disorder: A Double-Blind, Placebo-Controlled Trial
    Grant, Jon E.
    Driessens, Corine
    Chamberlain, Samuel R.
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (02) : 54 - 58
  • [26] Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
    Zwiep, J. C.
    Bet, P. M.
    Rhebergen, D.
    Nurmohamed, M. T.
    Vinkers, C. H.
    Penninx, B. W. J. H.
    Milaneschi, Y.
    Lamers, F.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2023, 27
  • [27] Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trial
    Fassett, Robert G.
    Robertson, Iain K.
    Ball, Madeleine J.
    Geraghty, Dominic P.
    Coombes, Jeff S.
    ATHEROSCLEROSIS, 2010, 213 (01) : 218 - 224
  • [28] An Internet-based Acceptance and Commitment Therapy intervention for older adults with anxiety complaints: study protocol for a cluster randomized controlled trial
    Witlox, Maartje
    Kraaij, Vivivan
    Garnefski, Nadia
    de Waal, Margot W. M.
    Smit, Filip
    Hoencamp, Erik
    Gussekloo, Jacobijn
    Bohlmeijer, Ernst T.
    Spinhoven, Philip
    TRIALS, 2018, 19
  • [29] Chronic Effects of a Wild Green Oat Extract Supplementation on Cognitive Performance in Older Adults: A Randomised, Double-Blind, Placebo-Controlled, Crossover Trial
    Wong, Rachel H. X.
    Howe, Peter R. C.
    Bryan, Janet
    Coates, Alison M.
    Buckley, Jonathan D.
    Berry, Narelle M.
    NUTRIENTS, 2012, 4 (05) : 331 - 342
  • [30] Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial
    Neeland, Ian J.
    Marso, Steven P.
    Ayers, Colby R.
    Lewis, Bienka
    Oslica, Robert
    Francis, Wynona
    Rodder, Susan
    Pandey, Ambarish
    Joshi, Parag H.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (09) : 595 - 605